BCL-2 in prostate cancer: A minireview

ISSN： 1360-8185

Source： Apoptosis, Vol.8, Iss.1, 2003-01, pp. : 29-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutation of BCL-2 Family Proteins in Cancer

By Packham G.

Apoptosis, Vol. 3, Iss. 2, 1998-03 ,pp. : 75-82

Springer Publishing Company

Access to resources Recommend Favorite

Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor

By Ray S. Bucur O. Almasan A.

Apoptosis, Vol. 10, Iss. 6, 2005-12 ,pp. : 1411-1418

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of Lipid Signaling Pathways for Cell Survival and Apoptosis by bcl-2 in Prostate Carcinoma Cells

By Herrmann J.L. Menter D.G. Beham A. Eschenbach A.v. McDonnell T.J.

Experimental Cell Research, Vol. 234, Iss. 2, 1997-08 ,pp. : 442-451

Elsevier

Access to resources Recommend Favorite

The Bcl-2 Protein Family

By Antonsson B. Martinou J.-C.

Experimental Cell Research, Vol. 256, Iss. 1, 2000-04 ,pp. : 50-57

Elsevier

Access to resources Recommend Favorite

Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells

By Pratt M. White Dawn Kushwaha Neena Tibbo Emma Niu Min

Apoptosis, Vol. 12, Iss. 4, 2007-04 ,pp. : 657-669

Springer Publishing Company

Access to resources Recommend Favorite